113 related articles for article (PubMed ID: 15543085)
1. Inhibition of human plasma leucine5-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugs.
Mosnaim AD; Puente J; Ranade V; Hoang C; Wolf ME
Am J Ther; 2004; 11(6):459-65. PubMed ID: 15543085
[TBL] [Abstract][Full Text] [Related]
2. In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure.
Mosnaim AD; Puente J; Saavedra R; Diamond S; Wolf ME
Pharmacology; 2003 Jan; 67(1):6-13. PubMed ID: 12444298
[TBL] [Abstract][Full Text] [Related]
3. Bacitracin-sensitive aminopeptidase(s) degradation of methionine(5)-enkephalin by human brain putamen and hippocampus preparations: inhibition by phenothiazine drugs.
Mosnaim AD; Saavedra R; Wolf ME
Am J Ther; 2009; 16(6):512-6. PubMed ID: 19797941
[TBL] [Abstract][Full Text] [Related]
4. Degradation kinetics of leucine5-enkephalin by plasma samples from healthy controls and various patient populations: in vitro drug effects.
Mosnaim AD; Wolf ME; Nguyen TD; Puente J; Freitag F; Diamond S
Am J Ther; 2000 May; 7(3):185-94. PubMed ID: 11317167
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of aminopeptidases from Aplysia californica.
Bawab W; Querido E; Crine P; DesGroseillers L
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
[TBL] [Abstract][Full Text] [Related]
6. Enkephalin hydrolysis by mouse plasma in vitro.
Shibanoki S; Weinberger SB; Schulteis G; Ishikawa K; Martinez JL
Life Sci; 1992; 50(10):667-75. PubMed ID: 1346713
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis of [Leu]enkephalin by chick plasma in vitro.
Shibanoki S; Weinberger SB; Beniston D; Nudelman KA; Schulteis G; Bennett EL; Rosenzweig MR; Ishikawa K; Martinez JL
J Pharmacol Exp Ther; 1991 Feb; 256(2):650-5. PubMed ID: 1994000
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
Weinberger SB; Martinez JL
J Pharmacol Exp Ther; 1988 Oct; 247(1):129-35. PubMed ID: 2902210
[TBL] [Abstract][Full Text] [Related]
9. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
Cohen ML; Geary LE; Wiley KS
J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
[TBL] [Abstract][Full Text] [Related]
10. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Giros B; Gros C; Solhonne B; Schwartz JC
Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
[TBL] [Abstract][Full Text] [Related]
11. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
Bausback HH; Ward PE
Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
[TBL] [Abstract][Full Text] [Related]
12. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
Friedman DI; Amidon GL
Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
[TBL] [Abstract][Full Text] [Related]
13. The aminopeptidase activity in the human T-cell lymphoma line (Jurkat) is not at the cell surface and is not aminopeptidase N (CD-13).
Murray H; Turner AJ; Kenny AJ
Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):353-60. PubMed ID: 7907864
[TBL] [Abstract][Full Text] [Related]
14. Characterization of enkephalin degradation in rat plasma.
Weinberger SB; Zafuto CE; Walker RC; Martinez JL
NIDA Res Monogr; 1986; 75():263-6. PubMed ID: 3123942
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms protecting plasma peptides from enzyme hydrolysis: a comparative study.
Venturelli F; Roscetti G; Roda LG
Comp Biochem Physiol B; 1987; 87(3):485-8. PubMed ID: 3621910
[TBL] [Abstract][Full Text] [Related]
16. Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations.
Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL
Regul Pept; 1991 Feb; 32(3):267-78. PubMed ID: 1678195
[TBL] [Abstract][Full Text] [Related]
17. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
Robertson MJ; Cunoosamy MP; Clark KL
Br J Pharmacol; 1992 May; 106(1):166-72. PubMed ID: 1354540
[TBL] [Abstract][Full Text] [Related]
18. N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid.
Benter IF; Hirsh EM; Tuchman AJ; Ward PE
Biochem Pharmacol; 1990 Aug; 40(3):465-72. PubMed ID: 1974424
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M.
Palmieri FE; Bausback HH; Ward PE
Biochem Pharmacol; 1989 Jan; 38(1):173-80. PubMed ID: 2462880
[TBL] [Abstract][Full Text] [Related]
20. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
